Vaxcyte IncNASDAQ:PCVX
- LAST PRICE88.5400
- TODAY'S CHANGE (%)0.1500 (0.1697%)
- Bid / Lots89.0000/ 1
- Ask / Lots94.2200/ 1
- Open / Previous Close88.4050 / 88.3900
- Day Range
- 52 Week Range
- Volume1,614,295
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PCVX |
|---|---|---|
| 09:32 ET | 4661 | 89.075 |
| 09:33 ET | 600 | 89.06 |
| 09:35 ET | 977 | 88.525 |
| 09:37 ET | 600 | 88.41 |
| 09:39 ET | 200 | 88.805 |
| 09:42 ET | 2396 | 88.8 |
| 09:44 ET | 1900 | 88.61 |
| 09:46 ET | 1024 | 88.79 |
| 09:48 ET | 1300 | 88.765 |
| 09:50 ET | 1495 | 88.695 |
| 09:51 ET | 2400 | 88.48 |
| 09:55 ET | 2007 | 88.48 |
| 09:57 ET | 2342 | 88.63 |
| 10:00 ET | 3629 | 88.96 |
| 10:02 ET | 4729 | 88.505 |
| 10:04 ET | 500 | 88.605 |
| 10:06 ET | 2247 | 88.58 |
| 10:08 ET | 500 | 88.9 |
| 10:09 ET | 2101 | 89.11 |
| 10:11 ET | 1850 | 89.07 |
| 10:13 ET | 19986 | 89.48 |
| 10:15 ET | 3563 | 89.58 |
| 10:18 ET | 700 | 89.535 |
| 10:20 ET | 1729 | 89.5 |
| 10:22 ET | 656 | 89.535 |
| 10:24 ET | 300 | 89.55 |
| 10:26 ET | 2400 | 89.22 |
| 10:27 ET | 753 | 89.175 |
| 10:29 ET | 31253 | 89.68 |
| 10:33 ET | 957 | 89.11 |
| 10:36 ET | 388 | 89.27 |
| 10:40 ET | 500 | 89.3959 |
| 10:42 ET | 683 | 89.58 |
| 10:44 ET | 500 | 89.6 |
| 10:45 ET | 200 | 89.645 |
| 10:47 ET | 2570 | 89.64 |
| 10:49 ET | 600 | 89.61 |
| 10:51 ET | 1350 | 89.49 |
| 10:54 ET | 1400 | 89.6 |
| 10:56 ET | 500 | 89.61 |
| 10:58 ET | 35779 | 90.4 |
| 11:00 ET | 2408 | 90.375 |
| 11:02 ET | 1453 | 90.5 |
| 11:03 ET | 16852 | 90.41 |
| 11:05 ET | 4100 | 90 |
| 11:07 ET | 200 | 89.82 |
| 11:09 ET | 8732 | 90.175 |
| 11:12 ET | 1419 | 90.05 |
| 11:14 ET | 640 | 90.285 |
| 11:16 ET | 352 | 90.3 |
| 11:18 ET | 1826 | 90.09 |
| 11:20 ET | 29099 | 89.975 |
| 11:21 ET | 1832 | 90.13 |
| 11:23 ET | 600 | 90.22 |
| 11:25 ET | 600 | 90.24 |
| 11:27 ET | 78665 | 90.24 |
| 11:30 ET | 300 | 90.27 |
| 11:32 ET | 900 | 90.34 |
| 11:34 ET | 2858 | 90.15 |
| 11:36 ET | 1053 | 90.05 |
| 11:38 ET | 614 | 90.05 |
| 11:39 ET | 300 | 90.06 |
| 11:41 ET | 200 | 90.045 |
| 11:43 ET | 1015 | 90.28 |
| 11:45 ET | 505 | 90.27 |
| 11:50 ET | 825 | 90.6 |
| 11:54 ET | 2608 | 90.305 |
| 11:56 ET | 618 | 90.36 |
| 11:57 ET | 500 | 90.39 |
| 11:59 ET | 100 | 90.46 |
| 12:01 ET | 500 | 90.45 |
| 12:03 ET | 300 | 90.56 |
| 12:06 ET | 1500 | 90.6 |
| 12:08 ET | 800 | 90.48 |
| 12:10 ET | 1449 | 90.39 |
| 12:14 ET | 2714 | 90.61 |
| 12:15 ET | 100 | 90.61 |
| 12:17 ET | 358 | 90.7 |
| 12:19 ET | 700 | 90.78 |
| 12:21 ET | 5535 | 90.915 |
| 12:24 ET | 3347 | 91.17 |
| 12:26 ET | 8892 | 91.095 |
| 12:28 ET | 5400 | 91.1 |
| 12:30 ET | 1043 | 90.955 |
| 12:32 ET | 3100 | 90.705 |
| 12:33 ET | 1405 | 90.485 |
| 12:35 ET | 400 | 90.425 |
| 12:37 ET | 600 | 90.64 |
| 12:39 ET | 300 | 90.71 |
| 12:42 ET | 548 | 90.7 |
| 12:44 ET | 873 | 90.78 |
| 12:46 ET | 3570 | 90.64 |
| 12:48 ET | 64074 | 90.73 |
| 12:50 ET | 1000 | 90.7 |
| 12:51 ET | 600 | 90.81 |
| 12:53 ET | 6737 | 90.89 |
| 12:55 ET | 2500 | 91.04 |
| 12:57 ET | 500 | 90.9775 |
| 01:00 ET | 1200 | 91.07 |
| 01:02 ET | 19822 | 90.96 |
| 01:04 ET | 1900 | 90.95 |
| 01:06 ET | 6100 | 90.945 |
| 01:08 ET | 2479 | 91 |
| 01:09 ET | 1400 | 91.075 |
| 01:11 ET | 1200 | 91.02 |
| 01:13 ET | 7789 | 91.035 |
| 01:15 ET | 6561 | 90.97 |
| 01:18 ET | 1463 | 90.975 |
| 01:20 ET | 3130 | 91.04 |
| 01:22 ET | 559 | 91.04 |
| 01:24 ET | 300 | 91.04 |
| 01:26 ET | 16514 | 90.9 |
| 01:27 ET | 1883 | 90.935 |
| 01:29 ET | 200 | 90.92 |
| 01:31 ET | 14102 | 90.595 |
| 01:33 ET | 2497 | 90.345 |
| 01:36 ET | 1600 | 90.27 |
| 01:38 ET | 2640 | 90.385 |
| 01:40 ET | 900 | 90.27 |
| 01:42 ET | 520 | 90.24 |
| 01:44 ET | 20800 | 90.37 |
| 01:45 ET | 220 | 90.26 |
| 01:47 ET | 284 | 90.265 |
| 01:49 ET | 2701 | 90.45 |
| 01:51 ET | 305 | 90.14 |
| 01:54 ET | 900 | 89.95 |
| 01:56 ET | 400 | 90.02 |
| 01:58 ET | 1253 | 90.075 |
| 02:00 ET | 200 | 90.08 |
| 02:02 ET | 300 | 90.15 |
| 02:03 ET | 4544 | 89.905 |
| 02:05 ET | 600 | 89.87 |
| 02:07 ET | 2700 | 89.68 |
| 02:09 ET | 3823 | 89.78 |
| 02:12 ET | 800 | 89.89 |
| 02:14 ET | 200 | 89.785 |
| 02:16 ET | 3800 | 89.57 |
| 02:18 ET | 1120 | 89.68 |
| 02:20 ET | 1525 | 89.55 |
| 02:21 ET | 3516 | 89.28 |
| 02:23 ET | 3413 | 89.14 |
| 02:25 ET | 5720 | 89.03 |
| 02:27 ET | 7820 | 89.235 |
| 02:30 ET | 10091 | 89.49 |
| 02:32 ET | 4981 | 89.5 |
| 02:34 ET | 3461 | 89.315 |
| 02:36 ET | 10125 | 89.215 |
| 02:38 ET | 7179 | 89.26 |
| 02:39 ET | 2417 | 89.57 |
| 02:41 ET | 1779 | 89.575 |
| 02:43 ET | 3083 | 89.495 |
| 02:45 ET | 2318 | 89.6 |
| 02:50 ET | 3086 | 89.46 |
| 02:52 ET | 4123 | 89.44 |
| 02:54 ET | 1182 | 89.33 |
| 02:56 ET | 1959 | 89.23 |
| 02:57 ET | 1378 | 89.18 |
| 02:59 ET | 1558 | 89.19 |
| 03:01 ET | 5235 | 89.48 |
| 03:03 ET | 3180 | 89.21 |
| 03:06 ET | 9857 | 89.45 |
| 03:08 ET | 4540 | 89.49 |
| 03:10 ET | 2815 | 89.54 |
| 03:12 ET | 3218 | 89.6 |
| 03:14 ET | 3324 | 89.595 |
| 03:15 ET | 6594 | 89.61 |
| 03:17 ET | 1000 | 89.6 |
| 03:19 ET | 4996 | 89.655 |
| 03:21 ET | 3005 | 89.71 |
| 03:24 ET | 2097 | 89.95 |
| 03:26 ET | 1249 | 90.12 |
| 03:28 ET | 5719 | 90.1 |
| 03:30 ET | 5440 | 90.15 |
| 03:32 ET | 7686 | 90.21 |
| 03:33 ET | 1040 | 90.2 |
| 03:35 ET | 653 | 90.24 |
| 03:37 ET | 3758 | 90.295 |
| 03:39 ET | 1973 | 90.25 |
| 03:42 ET | 3315 | 90.09 |
| 03:44 ET | 3161 | 90.155 |
| 03:46 ET | 4518 | 90.165 |
| 03:48 ET | 5924 | 89.95 |
| 03:50 ET | 7238 | 89.78 |
| 03:51 ET | 24406 | 89.45 |
| 03:53 ET | 12396 | 89.4 |
| 03:55 ET | 13666 | 88.995 |
| 03:57 ET | 60152 | 88.695 |
| 04:00 ET | 356234 | 88.54 |
Nov 20, 2024
Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm, from 2:46PM ET on Wednesday Nov 20, 2024 by Dow Jones
2:46PM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 12, 2024
Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs, from 7:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
7:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 6, 2024
DJ Vaxcyte Price Target Maintained With a $140.00/Share by Needham, from 6:14AM ET on Wednesday Nov 06, 2024 by Dow Jones
6:14AM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 5, 2024
Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update, from 4:01PM ET on Tuesday Nov 05, 2024 by Dow Jones
4:01PM ET on Tuesday Nov 05, 2024 by Dow Jones*DJ Vaxcyte 3Q Loss/Shr 83c >PCVX, from 4:01PM ET on Tuesday Nov 05, 2024 by Dow Jones
4:01PM ET on Tuesday Nov 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vaxcyte Inc | 11.0B | -19.5x | --- |
Revolution Medicines Inc | 9.5B | -15.8x | --- |
Summit Therapeutics Inc | 14.0B | -68.6x | --- |
Madrigal Pharmaceuticals Inc | 7.6B | -13.9x | --- |
Insmed Inc | 13.1B | -13.2x | --- |
Ascendis Pharma A/S | 7.9B | -16.7x | --- |
Company Information
Vaxcyte Inc. is a clinical-stage vaccine company. It is engaged in developing a spectrum conjugate and protein vaccines to prevent or treat bacterial infectious diseases. Its lead candidate, VAX-24, is a Phase III-ready 24-valent, carrier-sparing pneumococcal conjugate vaccine (PCV) being developed for the prevention of invasive pneumococcal disease (IPD). VAX-31, the Company’s next generation 31-valent PCV is developed for the prevention of IPD in adults. Its pipeline also includes VAX-A1, VAX-PG, and VAX-GI. VAX-A1, a novel conjugate vaccine candidate designed to prevent disease caused by Group A Streptococcus (Group A Strep). VAX-PG, a novel protein vaccine candidate targeting pathogen responsible for periodontitis, a chronic oral inflammatory disease. VAX-GI, a novel preclinical vaccine candidate being developed as a preventative treatment for dysentery and shigellosis. Its technology platform includes advanced chemistry and the XpressCF cell-free protein synthesis platform.
Contact Information
- Headquarters
- 825 INDUSTRIAL ROAD, STE. 300SAN CARLOS, CA, United States 94070
- Phone
- 650-837-0111
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Carlos Paya
- President, Chief Financial Officer
- Andrew Guggenhime
- Chief Executive Officer, Co-Founder, Director
- Grant Pickering
- Executive Vice President, Chief Operating Officer
- James Wassil
- Senior Vice President, General Counsel, Chief Compliance Officer, Corporate Secretary
- Mikhail Eydelman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.0B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 124.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.94 |
EPS | $-4.55 |
Book Value | $13.01 |
P/E Ratio | -19.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
